FormulationX To Debut At INTERPHEX 2018

International Pharmaceutical Expo the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference...

Titan pharmaceuticals receives fda clearance to begin clinical study of parkinson disease treatment

Titan Pharmaceuticals, Inc. announced that the U.S. FDA has cleared the IND application for its ropinirole implant intended for treatment of the signs and symptoms of Parkinson's disease.

Aquavit pharmaceuticals adds new patent to its high-tech medical portfolio

Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office has issued a patent for Apollo Technology, System and Method for Personalized Injection Treatment.Aquavit's European Patent issued by the EPO on July 27...

The Importance of the Human Touch in Improving Clinical Trial Patient-Centricity

Patient-centricity has become an important focus for drug developers and an essential element of clinical studies aimed at showing that a new therapy addresses real patient needs. How companies define patient-centric trials sometimes differ.

FDA approves Mylotarg for treatment of acute myeloid leukemia

Pfizer Inc. announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML).

Cmed Celebrates One Year Anniversary of encapsia

Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of Apps that helps biotech and pharma sponsors transform the way data is captured...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com